YearStart,YearEnd,LocationAbbr,LocationDesc,DataSource,Topic,Question,Response,DataValueUnit,DataValueType,DataValue,DataValueAlt,DataValueFootnoteSymbol,DatavalueFootnote,LowConfidenceLimit,HighConfidenceLimit,StratificationCategory1,Stratification1,StratificationCategory2,Stratification2,StratificationCategory3,Stratification3,GeoLocation,ResponseID,LocationID,TopicID,QuestionID,DataValueTypeID,StratificationCategoryID1,StratificationID1,StratificationCategoryID2,StratificationID2,StratificationCategoryID3,StratificationID3
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,22.6,22.6,,,16.4,30.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,20.2,20.2,,,14.6,27.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.5,10.5,,,6.6,16.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.0,14.0,,,10.0,19.2,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.7,5.7,,,4.1,7.8,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.1,9.1,,,8.0,10.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,23.9,43.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.4,12.4,,,8.5,17.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.7,9.7,,,5.6,16.4,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.6,6.6,,,4.2,10.5,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.8,87.8,,,83.3,91.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.2,11.2,,,8.9,14.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.1,75.1,,,55.0,88.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.5,10.5,,,6.3,16.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.6,8.6,,,6.9,10.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.6,45.6,,,37.5,54.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.1,29.1,,,18.1,43.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.5,8.5,,,7.2,9.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.1,44.1,,,35.0,53.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.8,13.8,,,8.5,21.5,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.7,81.7,,,69.1,90.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,17.5,17.5,,,9.7,29.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.3,34.3,,,26.0,43.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.1,10.1,,,8.5,11.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,59.6,59.6,,,42.7,74.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.3,74.3,,,63.1,83.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.5,8.5,,,6.5,11.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.9,45.9,,,36.6,55.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.8,75.8,,,65.1,84.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.2,14.2,,,10.1,19.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,19.7,19.7,,,10.6,33.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.7,10.7,,,8.5,13.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.8,10.8,,,7.9,14.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,61.6,61.6,,,46.0,75.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.8,37.8,,,29.0,47.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,67.9,67.9,,,51.1,81.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.2,33.2,,,24.7,43.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.1,30.1,,,21.4,40.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.2,13.2,,,8.4,20.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.6,11.6,,,6.7,19.2,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.0,13.0,,,8.4,19.6,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.3,8.3,,,7.2,9.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.1,38.1,,,26.1,51.8,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.5,10.5,,,8.4,13.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.4,13.4,,,8.3,20.9,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.9,9.9,,,8.5,11.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.2,83.2,,,72.1,90.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.0,13.0,,,8.2,20.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,20.1,20.1,,,11.2,33.4,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.6,29.6,,,22.1,38.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.3,38.3,,,24.9,53.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.8,39.8,,,26.6,54.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.0,71.0,,,59.0,80.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.0,42.0,,,26.1,59.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.3,8.3,,,7.1,9.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.2,8.2,,,6.1,10.8,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.9,8.9,,,7.6,10.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.6,31.6,,,23.3,41.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.0,38.0,,,29.0,47.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.1,9.1,,,7.6,10.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.5,84.5,,,75.2,90.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,64.3,64.3,,,53.4,73.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.1,13.1,,,7.2,22.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.6,13.6,,,9.7,18.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,63.5,63.5,,,52.5,73.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.4,83.4,,,73.3,90.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.9,12.9,,,7.5,21.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.6,11.6,,,8.0,16.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.0,12.0,,,8.0,17.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.1,29.1,,,21.7,37.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,27.9,46.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.3,7.3,,,4.9,10.8,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.0,14.0,,,11.1,17.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,68.5,68.5,,,59.3,76.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.8,85.8,,,76.3,92.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.8,10.8,,,9.7,12.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.9,6.9,,,5.7,8.4,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.1,13.1,,,8.8,19.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,8.6,8.6,,,6.1,11.8,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.9,38.9,,,32.7,45.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,30.4,43.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.9,15.9,,,10.3,23.7,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.5,13.5,,,9.1,19.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.7,34.7,,,25.8,44.8,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.2,86.2,,,77.6,91.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.8,38.8,,,32.8,45.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.3,10.3,,,9.4,11.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,69.3,69.3,,,60.7,76.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.7,40.7,,,34.7,47.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.1,7.1,,,4.9,10.2,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.9,33.9,,,23.5,46.2,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.5,32.5,,,23.1,43.5,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.0,14.0,,,9.0,21.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.9,33.9,,,23.1,46.7,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.1,7.1,,,5.8,8.6,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.2,37.2,,,28.2,47.1,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.8,46.8,,,38.1,55.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,9.4,9.4,,,6.9,12.8,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,15.8,15.8,,,10.1,23.9,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,18.4,18.4,,,13.3,24.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.9,9.9,,,8.6,11.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.2,39.2,,,29.6,49.6,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.2,15.2,,,11.1,20.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,27.0,45.9,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.8,7.8,,,6.5,9.3,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.0,34.0,,,25.4,43.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,73.4,73.4,,,60.9,83.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.8,5.8,,,3.9,8.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.7,52.7,,,43.6,61.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.0,10.0,,,8.5,11.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.7,7.7,,,6.4,9.2,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.7,37.7,,,27.9,48.6,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.7,84.7,,,72.2,92.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.9,72.9,,,60.2,82.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.1,36.1,,,27.4,45.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.7,5.7,,,3.8,8.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.0,85.0,,,73.3,92.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.1,15.1,,,9.8,22.5,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,15.1,15.1,,,10.8,20.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.7,9.7,,,6.6,13.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.2,43.2,,,33.1,53.8,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.9,9.9,,,6.8,14.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.5,46.5,,,38.3,55.0,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.2,73.2,,,63.0,81.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.3,42.3,,,32.3,53.1,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.2,7.2,,,4.5,11.2,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.5,13.5,,,11.3,16.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,89.7,89.7,,,82.5,94.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,24.4,24.4,,,13.9,39.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.4,9.4,,,8.0,11.0,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.0,42.0,,,33.0,51.6,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.4,38.4,,,33.2,43.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.6,7.6,,,4.9,11.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,59.6,59.6,,,54.4,64.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.2,9.2,,,7.8,10.8,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.8,75.8,,,67.1,82.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,90.1,90.1,,,83.2,94.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,15.8,15.8,,,10.7,22.7,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.9,10.9,,,10.0,11.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,58.3,58.3,,,53.1,63.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,31.3,42.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.6,13.6,,,10.6,17.2,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.2,15.2,,,10.3,21.9,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.9,10.9,,,10.0,11.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,20.4,20.4,,,11.8,32.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.1,10.1,,,8.8,11.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.6,13.6,,,11.2,16.4,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.3,28.3,,,15.9,45.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.7,30.7,,,24.5,37.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.6,11.6,,,6.7,19.4,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,58.4,58.4,,,51.5,65.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,17.6,17.6,,,13.3,22.9,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.6,14.6,,,11.1,19.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.4,85.4,,,76.9,91.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,69.2,69.2,,,55.4,80.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.4,36.4,,,27.6,46.2,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.4,31.4,,,25.1,38.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.6,11.6,,,6.5,19.9,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,59.9,59.9,,,52.7,66.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,23.8,23.8,,,16.0,34.0,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.1,7.1,,,4.7,10.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.5,14.5,,,10.8,19.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.1,35.1,,,25.9,45.4,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.3,85.3,,,76.6,91.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.7,69.7,,,54.1,81.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.8,5.8,,,3.4,9.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,24.3,24.3,,,15.8,35.5,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.9,6.9,,,4.4,10.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,11.7,11.7,,,9.1,15.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,55.6,55.6,,,38.4,71.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.6,9.6,,,8.5,10.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,24.3,24.3,,,14.0,38.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.5,13.5,,,10.9,16.6,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,53.5,53.5,,,38.4,68.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.9,7.9,,,4.6,13.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.4,14.4,,,11.8,17.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,16.9,16.9,,,9.6,28.1,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,72.2,72.2,,,59.4,82.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,16.3,16.3,,,9.1,27.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,17.4,17.4,,,11.3,25.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.8,14.8,,,11.9,18.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.5,8.5,,,4.9,14.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.7,28.7,,,19.8,39.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,18.0,18.0,,,9.9,30.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.3,39.3,,,28.1,51.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.5,13.5,,,9.2,19.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.0,36.0,,,25.8,47.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.9,11.9,,,6.8,20.0,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.1,26.1,,,18.7,35.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,16.9,16.9,,,10.0,27.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.2,10.2,,,5.7,17.5,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,75.9,75.9,,,65.5,84.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.9,8.9,,,6.7,11.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.2,9.2,,,7.3,11.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,19.7,19.7,,,12.1,30.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.2,28.2,,,18.7,40.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.3,77.3,,,63.7,86.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.9,52.9,,,41.6,63.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.5,12.5,,,8.0,19.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.0,86.0,,,70.1,94.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.7,36.7,,,23.1,52.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.1,41.1,,,26.0,58.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.8,13.8,,,10.2,18.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.1,9.1,,,7.7,10.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.5,13.5,,,10.1,17.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.5,74.5,,,58.7,85.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.7,40.7,,,24.8,58.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.1,38.1,,,23.6,55.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.0,13.0,,,7.3,22.1,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.8,9.8,,,7.9,12.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.2,9.2,,,5.6,14.9,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,51.4,51.4,,,38.9,63.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.9,8.9,,,5.3,14.6,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,25.9,25.9,,,16.3,38.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,83.5,83.5,,,74.4,89.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,89.1,89.1,,,77.3,95.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,25.8,25.8,,,17.5,36.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.4,27.4,,,17.8,39.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,4.3,4.3,,,2.5,7.5,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.9,74.9,,,53.6,88.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.6,9.6,,,8.5,11.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,61.8,61.8,,,42.2,78.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.4,47.4,,,39.4,55.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,4.2,4.2,,,2.8,6.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,64.8,64.8,,,45.9,79.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.2,10.2,,,8.8,11.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.8,78.8,,,59.4,90.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.9,37.9,,,30.8,45.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,16.4,16.4,,,11.9,22.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.0,11.0,,,9.0,13.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.4,6.4,,,3.5,11.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.8,70.8,,,60.1,79.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.5,46.5,,,38.0,55.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.8,84.8,,,76.9,90.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,4.4,4.4,,,2.8,6.6,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,18.5,18.5,,,14.4,23.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.2,38.2,,,30.4,46.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.3,6.3,,,3.6,10.8,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.9,10.9,,,8.9,13.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.0,29.0,,,20.9,38.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.4,10.4,,,5.8,18.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,71.0,71.0,,,60.3,79.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.5,84.5,,,76.0,90.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.3,29.3,,,20.8,39.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.5,6.5,,,5.4,7.8,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.7,75.7,,,60.6,86.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,25.0,25.0,,,15.6,37.6,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.3,79.3,,,67.9,87.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,69.3,69.3,,,49.0,84.2,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,21.3,21.3,,,12.3,34.3,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.0,41.0,,,30.0,53.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.3,15.3,,,10.0,22.7,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,24.2,24.2,,,15.4,35.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.4,47.4,,,33.4,61.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,77.9,77.9,,,65.8,86.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.8,6.8,,,5.7,8.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.8,27.8,,,18.3,39.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,78.7,78.7,,,65.9,87.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.1,10.1,,,8.2,12.4,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.6,41.6,,,30.5,53.5,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.1,39.1,,,27.2,52.4,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,21.2,21.2,,,12.1,34.6,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.9,32.9,,,20.0,49.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.2,10.2,,,6.3,16.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.1,50.1,,,34.9,65.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.6,6.6,,,5.0,8.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.5,46.5,,,35.7,57.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,16.6,16.6,,,13.0,20.8,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,17.0,17.0,,,11.3,24.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.7,39.7,,,28.0,52.6,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.8,32.8,,,21.8,46.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.7,6.7,,,5.4,8.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,77.5,77.5,,,64.9,86.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.1,69.1,,,47.5,84.6,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.0,29.0,,,21.4,38.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.0,10.0,,,8.1,12.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,16.4,16.4,,,12.9,20.6,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.8,75.8,,,60.7,86.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.5,43.5,,,33.4,54.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,7.8,7.8,,,5.2,11.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,19.5,19.5,,,11.2,31.7,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,17.8,17.8,,,12.0,25.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.3,45.3,,,39.1,51.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.8,49.8,,,43.8,55.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.5,46.5,,,40.4,52.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.5,11.5,,,6.9,18.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.1,9.1,,,8.2,10.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,22.8,22.8,,,13.7,35.4,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.4,49.4,,,43.4,55.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.1,5.1,,,3.3,7.9,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.8,8.8,,,8.0,9.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.7,5.7,,,3.7,8.7,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.3,87.3,,,80.7,91.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,18.4,18.4,,,12.3,26.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,78.1,78.1,,,70.0,84.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.3,11.3,,,6.7,18.2,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.5,12.5,,,10.1,15.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.5,87.5,,,81.0,92.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.1,78.1,,,70.1,84.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.7,84.7,,,75.8,90.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.1,73.1,,,64.1,80.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.9,10.9,,,6.4,17.9,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,73.2,73.2,,,64.1,80.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.8,33.8,,,27.8,40.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.3,9.3,,,8.3,10.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.0,11.0,,,6.2,18.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.9,10.9,,,8.7,13.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.9,31.9,,,25.9,38.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.0,40.0,,,33.8,46.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.0,11.0,,,7.9,15.1,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.5,10.5,,,7.6,14.4,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.5,40.5,,,34.4,47.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.4,14.4,,,8.1,24.4,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.3,86.3,,,78.6,91.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.6,14.6,,,9.0,23.0,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.3,9.3,,,8.5,10.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.1,11.1,,,6.1,19.3,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.2,8.2,,,6.9,9.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.6,14.6,,,8.0,25.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.4,8.4,,,6.9,10.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.2,49.2,,,37.9,60.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.0,36.0,,,25.4,48.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,11.5,11.5,,,7.5,17.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.0,50.0,,,38.5,61.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.2,84.2,,,66.8,93.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.1,36.1,,,25.4,48.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,83.1,83.1,,,67.2,92.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.6,9.6,,,6.8,13.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.9,85.9,,,72.6,93.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.0,82.0,,,66.3,91.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.2,10.2,,,7.2,14.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.8,43.8,,,38.4,49.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.4,39.4,,,33.8,45.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.9,9.9,,,9.1,10.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.9,6.9,,,4.8,10.0,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.0,15.0,,,12.7,17.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.6,15.6,,,10.5,22.6,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.0,10.0,,,9.1,10.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.0,8.0,,,5.5,11.3,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,18.2,18.2,,,11.7,27.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.4,14.4,,,9.3,21.6,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.5,74.5,,,67.6,80.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.8,84.8,,,78.3,89.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,22.3,22.3,,,13.4,34.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.6,30.6,,,19.7,44.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.7,10.7,,,7.5,15.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,21.2,21.2,,,13.2,32.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.2,14.2,,,8.9,21.7,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.3,15.3,,,12.3,18.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.7,84.7,,,78.4,89.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.3,37.3,,,31.4,43.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.7,73.7,,,66.7,79.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.4,42.4,,,37.2,47.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.8,33.8,,,22.0,48.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.7,10.7,,,7.4,15.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,15.6,15.6,,,12.4,19.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.5,10.5,,,9.8,11.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.8,48.8,,,44.9,52.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,83.7,83.7,,,78.1,88.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.3,10.3,,,7.5,14.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.5,42.5,,,38.5,46.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.8,74.8,,,68.9,79.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,21.6,48.5,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.0,43.0,,,30.5,56.4,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,37.5,37.5,,,25.1,51.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.6,10.6,,,10.0,11.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.4,10.4,,,7.5,14.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.5,13.5,,,11.9,15.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.8,73.8,,,67.9,79.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.9,82.9,,,77.3,87.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.4,37.4,,,24.4,52.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.3,15.3,,,9.5,23.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.3,8.3,,,6.3,10.7,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.1,11.1,,,8.5,14.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.6,36.6,,,23.5,52.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,22.6,22.6,,,17.4,28.9,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.0,12.0,,,8.4,17.0,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.8,46.8,,,43.1,50.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.1,9.1,,,7.1,11.7,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.8,38.8,,,35.1,42.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,22.6,22.6,,,16.8,29.7,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.6,37.6,,,24.6,52.6,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.1,11.1,,,8.6,14.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.8,46.8,,,33.7,60.4,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.7,75.7,,,63.8,84.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,67.5,67.5,,,55.6,77.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.3,11.3,,,10.1,12.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.3,11.3,,,10.1,12.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,17.1,17.1,,,9.6,28.6,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.5,14.5,,,11.5,18.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,68.3,68.3,,,56.6,78.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.7,38.7,,,32.4,45.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.0,34.0,,,27.5,41.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.9,37.9,,,31.3,45.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.7,13.7,,,9.2,19.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.1,37.1,,,30.7,44.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,76.9,76.9,,,65.9,85.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,5.9,5.9,,,3.5,9.8,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.6,13.6,,,9.2,19.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.4,12.4,,,9.9,15.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.7,14.7,,,9.4,22.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.6,85.6,,,71.0,93.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.1,35.1,,,26.4,44.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.5,75.5,,,61.0,85.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.0,38.0,,,28.9,48.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.4,9.4,,,5.2,16.4,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.2,40.2,,,31.8,49.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.1,9.1,,,5.4,14.8,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.2,10.2,,,7.6,13.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.2,40.2,,,31.5,49.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.2,27.2,,,19.3,36.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.0,8.0,,,6.9,9.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.0,8.0,,,6.9,9.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.9,28.9,,,19.4,40.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.1,28.1,,,18.1,40.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.3,12.3,,,9.9,15.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.6,27.6,,,17.6,40.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,78.0,78.0,,,65.7,86.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.0,86.0,,,71.4,93.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,16.4,16.4,,,9.2,27.5,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.6,10.6,,,5.9,18.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.9,6.9,,,4.9,9.6,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.5,11.5,,,8.9,14.8,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,53.6,53.6,,,47.2,59.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.7,33.7,,,26.9,41.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.7,12.7,,,11.5,14.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.6,39.6,,,32.2,47.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.8,38.8,,,32.5,45.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,17.5,17.5,,,10.0,29.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.2,9.2,,,8.2,10.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.9,80.9,,,68.5,89.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,21.9,21.9,,,18.1,26.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,23.7,23.7,,,13.6,38.0,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.7,13.7,,,10.8,17.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.2,13.2,,,11.9,14.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.9,10.9,,,8.5,13.7,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.7,12.7,,,8.5,18.6,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,64.4,64.4,,,50.7,76.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.3,35.3,,,28.7,42.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,16.0,16.0,,,9.2,26.4,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.2,6.2,,,4.5,8.5,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,60.6,60.6,,,54.6,66.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.6,50.6,,,37.8,63.3,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,88.0,88.0,,,81.9,92.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.9,8.9,,,8.1,9.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,62.9,62.9,,,56.9,68.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.6,35.6,,,29.4,42.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,16.1,16.1,,,12.6,20.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.7,26.7,,,15.1,42.6,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.6,10.6,,,7.3,15.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.0,27.0,,,17.3,39.6,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,92.8,92.8,,,87.8,95.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.7,77.7,,,69.9,83.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.1,29.1,,,17.4,44.3,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.1,12.1,,,8.2,17.4,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.3,77.3,,,64.3,86.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.0,8.0,,,5.7,11.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.2,40.2,,,32.2,48.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.3,10.3,,,7.2,14.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.0,8.0,,,4.7,13.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.8,32.8,,,25.7,40.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.6,11.6,,,10.2,13.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.3,51.3,,,37.8,64.5,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.7,37.7,,,30.5,45.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.7,76.7,,,68.4,83.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,83.4,83.4,,,72.3,90.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.1,7.1,,,4.3,11.6,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,66.7,66.7,,,52.1,78.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.5,8.5,,,5.9,11.9,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.9,76.9,,,62.2,87.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.7,87.7,,,81.0,92.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.7,13.7,,,9.3,19.6,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,92.4,92.4,,,87.2,95.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.3,52.3,,,45.5,59.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.5,11.5,,,10.1,13.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.4,8.4,,,4.9,14.2,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.2,12.2,,,11.3,13.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.7,80.7,,,75.7,84.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,20.6,20.6,,,13.0,31.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,17.4,17.4,,,10.9,26.8,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,18.3,18.3,,,15.5,21.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,16.8,16.8,,,10.0,26.9,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.8,8.8,,,5.3,14.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.8,81.8,,,77.1,85.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,89.0,89.0,,,85.1,92.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.4,42.4,,,37.4,47.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.6,12.6,,,11.5,13.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.3,48.3,,,43.3,53.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,19.5,19.5,,,11.9,30.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.7,46.7,,,41.4,52.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.5,37.5,,,32.6,42.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.4,49.4,,,43.8,55.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.7,13.7,,,11.2,16.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.3,42.3,,,36.6,48.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.2,33.2,,,23.0,45.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.5,11.5,,,10.5,12.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.6,11.6,,,7.3,17.7,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.7,9.7,,,6.2,15.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.7,34.7,,,24.2,46.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.0,12.0,,,10.9,13.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,16.3,16.3,,,11.3,22.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.2,41.2,,,35.6,47.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.2,30.2,,,20.1,42.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.3,11.3,,,7.5,16.8,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.6,9.6,,,6.0,15.2,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.5,48.5,,,42.9,54.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.4,28.4,,,19.0,40.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.8,8.8,,,6.0,12.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,17.0,17.0,,,14.3,20.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.3,74.3,,,66.1,81.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,73.8,73.8,,,64.9,81.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.6,13.6,,,11.2,16.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.9,84.9,,,78.8,89.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.9,85.9,,,80.1,90.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.0,9.0,,,6.1,13.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,11.2,11.2,,,7.1,17.3,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,18.6,18.6,,,10.5,30.6,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.6,8.6,,,8.0,9.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,88.1,88.1,,,83.0,91.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.8,12.8,,,7.6,20.8,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,18.9,18.9,,,13.8,25.4,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.6,7.6,,,5.6,10.3,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.7,8.7,,,8.1,9.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,16.0,16.0,,,10.0,24.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.7,49.7,,,35.8,63.6,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.6,6.6,,,4.9,8.7,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,19.7,19.7,,,14.3,26.5,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.7,55.7,,,51.2,60.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.8,83.8,,,74.8,90.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.2,10.2,,,7.6,13.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.5,8.5,,,6.0,12.0,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,88.0,88.0,,,83.0,91.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.6,12.6,,,10.9,14.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.4,75.4,,,68.9,81.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.3,40.3,,,36.1,44.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.2,75.2,,,68.3,81.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.1,39.1,,,34.6,43.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.1,8.1,,,5.9,11.0,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.6,48.6,,,32.5,65.0,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,56.1,56.1,,,51.8,60.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.6,10.6,,,7.9,14.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.5,86.5,,,78.5,91.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.1,9.1,,,8.2,10.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.7,13.7,,,11.3,16.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.6,36.6,,,23.4,52.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.6,7.6,,,4.2,13.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.8,10.8,,,8.3,13.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.7,7.7,,,4.3,13.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.1,35.1,,,22.2,50.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,71.3,71.3,,,62.3,79.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.8,14.8,,,9.4,22.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.1,37.1,,,23.7,52.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.8,46.8,,,40.8,52.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.7,84.7,,,74.9,91.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,73.3,73.3,,,65.0,80.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.0,11.0,,,8.5,14.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.3,39.3,,,24.8,56.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.4,9.4,,,8.5,10.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.1,47.1,,,41.1,53.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.0,11.0,,,6.9,17.0,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.4,39.4,,,33.5,45.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,15.4,15.4,,,10.1,22.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.5,14.5,,,9.7,21.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.6,41.6,,,35.6,48.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.2,12.2,,,7.7,18.8,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,78.0,78.0,,,64.7,87.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.3,9.3,,,7.9,11.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,64.3,64.3,,,48.5,77.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.2,30.2,,,21.7,40.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,22.0,22.0,,,14.2,32.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,11.7,11.7,,,7.5,17.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.4,27.4,,,18.4,38.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.7,40.7,,,31.5,50.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.7,80.7,,,67.1,89.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.7,10.7,,,8.7,13.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.5,10.5,,,8.5,12.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.9,39.9,,,31.0,49.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.3,9.3,,,7.9,10.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.2,12.2,,,8.6,17.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.6,33.6,,,24.9,43.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,23.4,23.4,,,15.2,34.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.3,29.3,,,19.7,41.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,64.1,64.1,,,48.3,77.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,17.7,17.7,,,11.4,26.5,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.1,12.1,,,7.4,19.1,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.9,40.9,,,34.6,47.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.9,9.9,,,8.8,11.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.9,39.9,,,33.0,47.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,19.0,19.0,,,11.8,29.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.4,41.4,,,34.9,48.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.1,9.1,,,6.3,13.0,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,89.7,89.7,,,83.0,93.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.4,77.4,,,68.8,84.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.4,40.4,,,33.7,47.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.1,9.1,,,6.2,13.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.4,14.4,,,11.4,18.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,89.4,89.4,,,82.4,93.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,77.1,77.1,,,68.4,84.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.6,12.6,,,7.5,20.2,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.6,9.6,,,8.6,10.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.4,8.4,,,7.2,9.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.7,45.7,,,35.9,55.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.5,27.5,,,17.5,40.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.8,49.8,,,40.4,59.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.7,29.7,,,19.1,43.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,3.5,3.5,,,2.0,6.2,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.0,13.0,,,7.4,21.7,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,89.6,89.6,,,79.0,95.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.2,9.2,,,5.8,14.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,60.4,60.4,,,45.0,73.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.8,11.8,,,9.3,14.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,88.8,88.8,,,77.8,94.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,11.4,11.4,,,8.4,15.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.2,41.2,,,32.0,51.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,63.2,63.2,,,47.8,76.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.8,30.8,,,19.8,44.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.8,49.8,,,40.6,59.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.9,8.9,,,5.4,14.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.7,11.7,,,9.3,14.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.4,8.4,,,7.3,9.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.4,10.4,,,7.8,13.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.0,45.0,,,37.4,52.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.1,8.1,,,7.2,9.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.0,52.0,,,44.0,59.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.2,52.2,,,44.5,59.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.9,10.9,,,6.8,17.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.8,80.8,,,72.6,87.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.9,10.9,,,7.1,16.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,80.9,80.9,,,72.8,87.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.4,10.4,,,6.7,15.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.2,87.2,,,82.6,90.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.3,71.3,,,64.2,77.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.3,37.3,,,30.6,44.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.3,82.3,,,75.8,87.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.0,85.0,,,78.2,90.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.2,51.2,,,44.4,57.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.0,6.0,,,3.3,10.6,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.4,13.4,,,11.9,15.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.0,72.0,,,65.2,77.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.6,86.6,,,82.0,90.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,5.4,5.4,,,3.1,9.2,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,54.1,54.1,,,48.7,59.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.6,11.6,,,7.0,18.6,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.1,34.1,,,27.4,41.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.4,38.4,,,33.3,43.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.9,49.9,,,43.0,56.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.0,7.0,,,4.9,9.7,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.1,9.1,,,5.2,15.7,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.7,8.7,,,8.0,9.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.5,8.5,,,7.8,9.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.8,12.8,,,11.6,14.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.5,83.5,,,76.3,88.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,19.0,19.0,,,15.2,23.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.9,80.9,,,73.7,86.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.0,13.0,,,11.0,15.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.4,54.4,,,48.9,59.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.7,10.7,,,6.9,16.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.4,39.4,,,34.1,45.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.5,30.5,,,20.8,42.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,56.3,56.3,,,47.5,64.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.7,13.7,,,9.1,20.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,15.8,15.8,,,9.1,26.1,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.8,86.8,,,78.2,92.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.9,9.9,,,8.4,11.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.2,9.2,,,8.0,10.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,55.5,55.5,,,45.9,64.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.7,31.7,,,21.8,43.5,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,18.0,18.0,,,13.2,24.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.7,44.7,,,33.7,56.2,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.2,6.2,,,4.1,9.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.2,31.2,,,20.8,43.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.0,75.0,,,63.9,83.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.4,11.4,,,9.1,14.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.3,6.3,,,4.0,9.8,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.7,30.7,,,19.5,44.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.7,45.7,,,35.9,55.8,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.8,50.8,,,38.9,62.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.4,73.4,,,61.9,82.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.0,32.0,,,22.4,43.4,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.6,11.6,,,9.2,14.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.1,10.1,,,7.2,14.0,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.6,8.6,,,7.1,10.5,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.9,52.9,,,39.7,65.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,16.5,16.5,,,9.6,26.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.5,8.5,,,7.0,10.2,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.3,87.3,,,79.1,92.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.3,33.3,,,21.3,47.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.8,40.8,,,31.5,50.7,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.2,40.2,,,31.7,49.4,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.0,52.0,,,42.2,61.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.3,10.3,,,8.8,12.0,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.4,11.4,,,9.9,13.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.4,7.4,,,5.4,10.0,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.4,10.4,,,8.9,12.2,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.2,44.2,,,34.4,54.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.7,39.7,,,31.3,48.8,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.4,76.4,,,66.2,84.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.7,52.7,,,41.8,63.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.9,44.9,,,32.9,57.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.8,7.8,,,5.7,10.6,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.3,82.3,,,73.0,88.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,16.5,16.5,,,12.8,21.0,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.0,79.0,,,70.5,85.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.4,84.4,,,76.6,89.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.5,37.5,,,28.8,47.0,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.5,11.5,,,9.7,13.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,8.5,8.5,,,4.8,14.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,16.1,16.1,,,11.1,22.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.4,12.4,,,7.4,20.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.8,10.8,,,8.8,13.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.7,5.7,,,3.8,8.3,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.7,39.7,,,27.8,53.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.8,29.8,,,18.8,43.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.4,43.4,,,30.5,57.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.9,5.9,,,4.0,8.8,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.4,32.4,,,20.1,47.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.4,74.4,,,49.6,89.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,65.3,65.3,,,43.4,82.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,62.2,62.2,,,44.6,77.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.2,11.2,,,9.9,12.7,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.8,14.8,,,10.2,20.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.8,32.8,,,26.0,40.3,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.3,42.3,,,35.3,49.6,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,55.2,55.2,,,34.2,74.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,39.9,39.9,,,22.4,60.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.3,12.3,,,9.2,16.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.1,10.1,,,9.3,11.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,39.4,39.4,,,21.2,61.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.2,52.2,,,34.2,69.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.2,11.2,,,9.9,12.6,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.6,33.6,,,26.1,42.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,52.8,52.8,,,34.2,70.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.2,14.2,,,10.3,19.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.6,29.6,,,22.0,38.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.8,30.8,,,19.8,44.6,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.1,38.1,,,24.3,54.2,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.8,48.8,,,32.8,65.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.8,31.8,,,28.0,35.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.9,47.9,,,43.4,52.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.6,49.6,,,31.3,68.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,11.2,11.2,,,9.1,13.9,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.7,9.7,,,9.0,10.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,19.5,19.5,,,10.8,32.5,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,39.9,39.9,,,24.1,58.2,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.8,49.8,,,28.7,71.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.0,31.0,,,23.1,40.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,51.1,51.1,,,32.7,69.2,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.4,31.4,,,24.2,39.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,29.8,37.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.4,6.4,,,4.9,8.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.7,48.7,,,44.3,53.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,76.8,76.8,,,71.0,81.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.6,47.6,,,32.5,63.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.1,11.1,,,9.6,12.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,6.7,6.7,,,4.1,10.6,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.1,82.1,,,75.9,87.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,41.6,41.6,,,28.7,55.8,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.7,13.7,,,11.5,16.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,26.1,40.7,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,51.5,51.5,,,33.8,68.9,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.4,6.4,,,4.9,8.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.4,43.4,,,36.2,51.0,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.9,76.9,,,71.4,81.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.2,11.2,,,9.7,12.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.4,82.4,,,76.7,87.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.4,87.4,,,80.5,92.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.0,39.0,,,34.0,44.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.4,52.4,,,37.8,66.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,72.7,72.7,,,64.6,79.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.3,11.3,,,9.0,14.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.9,5.9,,,3.6,9.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.7,15.7,,,13.2,18.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.2,37.2,,,32.1,42.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.4,9.4,,,6.4,13.7,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.8,52.8,,,37.6,67.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,25.6,25.6,,,14.5,41.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.5,10.5,,,9.6,11.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.3,5.3,,,3.2,8.8,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.5,11.5,,,7.6,17.0,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.1,50.1,,,36.2,64.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.6,33.6,,,19.5,51.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.0,42.0,,,37.0,47.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.2,10.2,,,9.4,11.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.0,12.0,,,7.5,18.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,21.9,21.9,,,16.0,29.2,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.7,70.7,,,62.9,77.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.4,87.4,,,81.3,91.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.8,33.8,,,18.5,53.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.2,11.2,,,8.9,14.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.1,47.1,,,32.3,62.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.5,43.5,,,38.6,48.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,19.7,19.7,,,14.5,26.2,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.0,14.0,,,9.9,19.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.3,86.3,,,78.0,91.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.6,81.6,,,72.5,88.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.9,35.9,,,29.4,42.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.9,13.9,,,9.7,19.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.6,86.6,,,78.6,92.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.8,35.8,,,28.4,43.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.9,81.9,,,73.1,88.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.1,37.1,,,30.2,44.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.5,10.5,,,9.3,11.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.5,6.5,,,4.3,9.7,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,28.0,28.0,,,16.3,43.7,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.9,34.9,,,27.7,42.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.1,11.1,,,8.1,15.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.7,10.7,,,9.4,12.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.4,6.4,,,4.2,9.6,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.8,10.8,,,7.9,14.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.2,15.2,,,12.0,19.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.6,8.6,,,5.5,13.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,93.4,93.4,,,87.6,96.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.8,71.8,,,60.5,80.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.1,42.1,,,35.6,48.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.1,52.1,,,45.8,58.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,25.5,25.5,,,15.8,38.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.3,8.3,,,5.3,12.6,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.5,11.5,,,10.4,12.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.2,15.2,,,12.5,18.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,92.9,92.9,,,86.9,96.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.5,70.5,,,58.2,80.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.8,7.8,,,5.4,11.1,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.7,11.7,,,10.5,13.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,19.4,19.4,,,12.7,28.5,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.6,7.6,,,5.5,10.5,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,7.8,7.8,,,4.6,13.1,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,17.6,17.6,,,11.2,26.7,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.8,39.8,,,33.4,46.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,25.3,25.3,,,16.0,37.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.2,49.2,,,43.3,55.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.7,12.7,,,8.1,19.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.8,47.8,,,40.6,55.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.9,38.9,,,31.8,46.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.8,5.8,,,3.4,9.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.0,85.0,,,77.3,90.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.1,15.1,,,11.9,19.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.4,84.4,,,75.3,90.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,17.5,17.5,,,10.3,28.1,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.2,84.2,,,76.5,89.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.7,5.7,,,3.3,9.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.1,85.1,,,76.8,90.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.9,14.9,,,11.8,18.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.9,30.9,,,21.7,42.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.6,26.6,,,17.0,39.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.6,9.6,,,8.5,10.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.3,13.3,,,9.4,18.3,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,22.3,47.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.3,30.3,,,19.6,43.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.7,35.7,,,29.3,42.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.8,15.8,,,12.4,19.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.9,9.9,,,8.8,11.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.0,47.0,,,39.9,54.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,56.5,56.5,,,48.9,63.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.2,46.2,,,32.2,60.7,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,22.8,22.8,,,14.0,35.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,54.7,54.7,,,42.2,66.6,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,53.8,53.8,,,40.4,66.7,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.1,10.1,,,7.8,13.0,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,20.6,20.6,,,12.0,33.1,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.1,55.1,,,47.8,62.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.4,11.4,,,10.2,12.8,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.3,70.3,,,59.4,79.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.9,10.9,,,8.5,13.8,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.5,13.5,,,11.9,15.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.8,15.8,,,12.1,20.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.0,46.0,,,32.2,60.4,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.3,70.3,,,59.0,79.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.5,14.5,,,9.5,21.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.4,11.4,,,10.1,12.8,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,56.6,56.6,,,44.7,67.8,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.2,13.2,,,10.5,16.5,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,53.5,53.5,,,41.1,65.4,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.1,12.1,,,7.5,19.0,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.0,13.0,,,11.6,14.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,9.9,9.9,,,6.1,15.5,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.4,14.4,,,9.5,21.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.8,29.8,,,23.9,36.4,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,17.5,17.5,,,13.2,22.8,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.7,29.7,,,23.7,36.5,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.3,12.3,,,7.8,19.0,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,19.2,19.2,,,14.4,25.2,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.5,33.5,,,26.9,40.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.2,86.2,,,76.0,92.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.0,7.0,,,3.9,12.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,79.2,79.2,,,62.9,89.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.3,35.3,,,28.5,42.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,11.0,11.0,,,8.3,14.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.0,71.0,,,62.1,78.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.1,85.1,,,78.5,89.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,68.5,68.5,,,48.9,83.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.3,44.3,,,36.8,52.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,28.7,43.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.0,47.0,,,39.9,54.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.9,6.9,,,4.0,11.5,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.1,9.1,,,8.1,10.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.6,31.6,,,23.9,40.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,66.4,66.4,,,46.9,81.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.1,84.1,,,77.2,89.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.1,32.1,,,21.1,45.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.7,9.7,,,7.7,12.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.5,31.5,,,20.8,44.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.8,36.8,,,25.2,50.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.4,86.4,,,75.9,92.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.9,9.9,,,7.9,12.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.3,39.3,,,28.6,51.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,4.8,4.8,,,2.9,8.0,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.9,69.9,,,61.4,77.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.4,81.4,,,67.6,90.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.4,42.4,,,31.1,54.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,88.0,88.0,,,74.2,94.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,57.7,57.7,,,46.2,68.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,92.5,92.5,,,78.4,97.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.3,30.3,,,15.8,50.2,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,66.5,66.5,,,46.5,82.0,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.1,45.1,,,32.0,58.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,58.2,58.2,,,45.3,70.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.1,30.1,,,17.9,45.9,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,57.6,57.6,,,45.7,68.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,8.6,8.6,,,5.8,12.5,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.6,8.6,,,7.0,10.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,88.9,88.9,,,76.9,95.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.3,7.3,,,4.9,10.8,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,93.1,93.1,,,80.9,97.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,11.7,11.7,,,7.7,17.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.0,11.0,,,7.7,15.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,89.7,89.7,,,80.9,94.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.6,12.6,,,9.8,15.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,90.0,90.0,,,81.3,94.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.2,50.2,,,42.8,57.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.0,11.0,,,7.8,15.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.0,79.0,,,68.7,86.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,18.4,18.4,,,10.9,29.5,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.8,9.8,,,8.6,11.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.0,51.0,,,43.5,58.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.6,43.6,,,35.9,51.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,17.8,17.8,,,10.9,27.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.5,76.5,,,64.9,85.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,29.7,44.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,18.2,18.2,,,10.3,29.9,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.8,9.8,,,8.7,11.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,18.0,18.0,,,10.0,30.1,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.3,34.3,,,22.7,48.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,91.6,91.6,,,83.6,95.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.0,27.0,,,15.2,43.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.5,40.5,,,31.7,49.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.6,45.6,,,37.3,54.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,73.5,73.5,,,62.7,82.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,90.8,90.8,,,82.7,95.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.7,10.7,,,8.0,14.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,26.1,26.1,,,14.7,42.1,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,11.8,11.8,,,8.4,16.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.8,37.8,,,25.9,51.3,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.5,73.5,,,62.4,82.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.9,9.9,,,8.5,11.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.3,6.3,,,5.0,7.9,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.2,36.2,,,25.5,48.4,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.3,15.3,,,8.9,25.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,25.8,25.8,,,16.2,38.4,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.1,10.1,,,8.9,11.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.2,6.2,,,5.0,7.8,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,8.2,8.2,,,5.8,11.5,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.5,37.5,,,22.8,54.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.8,27.8,,,15.6,44.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.2,43.2,,,34.4,52.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.4,34.4,,,26.3,43.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.9,10.9,,,8.1,14.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.2,7.2,,,5.6,9.3,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.2,48.2,,,43.4,53.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.1,37.1,,,32.2,42.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.3,7.3,,,5.7,9.2,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.4,36.4,,,24.6,50.1,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,21.2,49.0,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.8,75.8,,,68.5,82.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.6,87.6,,,81.6,91.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.0,47.0,,,42.0,52.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.9,36.9,,,31.9,42.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.3,5.3,,,3.3,8.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.6,34.6,,,22.3,49.4,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.4,10.4,,,9.6,11.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.8,34.8,,,23.5,48.2,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.1,87.1,,,80.9,91.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.1,13.1,,,11.1,15.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.8,75.8,,,68.6,81.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.9,5.9,,,3.7,9.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.4,10.4,,,9.6,11.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.8,11.8,,,9.7,14.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.5,14.5,,,8.4,23.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.5,55.5,,,49.1,61.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.3,44.3,,,37.8,50.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,8.5,8.5,,,4.7,14.9,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,91.1,91.1,,,85.2,94.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.0,12.0,,,10.0,14.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,76.0,76.0,,,66.4,83.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.4,9.4,,,6.5,13.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,55.9,55.9,,,49.4,62.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,90.8,90.8,,,85.1,94.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.3,37.3,,,26.7,49.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.0,32.0,,,22.2,43.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.3,76.3,,,67.4,83.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.5,9.5,,,6.5,13.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.2,9.2,,,6.4,13.0,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.0,9.0,,,8.2,9.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.3,13.3,,,10.9,16.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.6,38.6,,,27.9,50.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.9,40.9,,,30.4,52.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,17.2,17.2,,,10.8,26.5,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.3,9.3,,,6.6,13.1,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.2,43.2,,,36.6,50.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.2,9.2,,,8.2,10.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.4,15.4,,,10.5,21.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.5,5.5,,,3.4,9.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,4.9,4.9,,,3.0,8.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,16.5,16.5,,,8.9,28.5,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,88.1,88.1,,,81.6,92.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.4,36.4,,,29.7,43.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.4,87.4,,,80.5,92.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.4,15.4,,,12.0,19.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.6,49.6,,,42.7,56.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.2,12.2,,,10.8,13.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.7,81.7,,,73.3,87.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.4,12.4,,,7.0,21.0,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,83.3,83.3,,,75.9,88.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.0,51.0,,,44.2,57.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.7,11.7,,,10.5,13.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.0,40.0,,,33.2,47.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,16.7,16.7,,,12.6,21.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.3,49.3,,,36.4,62.2,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.5,31.5,,,21.0,44.4,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.2,86.2,,,80.8,90.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.7,10.7,,,7.1,15.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.7,78.7,,,72.9,83.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.7,10.7,,,7.2,15.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,17.5,17.5,,,9.9,29.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.8,8.8,,,6.7,11.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,16.8,16.8,,,14.3,19.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,62.7,62.7,,,48.7,74.9,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.7,8.7,,,6.7,11.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.9,51.9,,,38.2,65.5,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.6,36.6,,,23.7,51.9,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.7,86.7,,,81.1,90.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.6,12.6,,,8.0,19.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.5,7.5,,,5.8,9.6,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.9,43.9,,,38.9,49.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.2,79.2,,,72.9,84.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.5,11.5,,,10.6,12.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.3,48.3,,,43.4,53.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,24.6,50.6,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.4,7.4,,,5.8,9.4,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,16.2,16.2,,,12.0,21.4,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.0,48.0,,,42.7,53.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,6.7,6.7,,,4.0,11.1,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,60.0,60.0,,,43.4,74.5,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.1,42.1,,,36.7,47.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.5,33.5,,,19.7,50.9,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.2,11.2,,,10.4,12.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.6,50.6,,,43.2,57.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.6,47.6,,,39.4,56.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,35.2,35.2,,,19.9,54.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,24.8,24.8,,,15.6,37.2,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.6,10.6,,,9.3,12.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,15.1,15.1,,,9.1,23.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,77.1,77.1,,,67.9,84.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.2,82.2,,,72.2,89.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.3,9.3,,,5.4,15.4,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.5,49.5,,,41.9,57.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.9,14.9,,,11.4,19.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.3,50.3,,,42.8,57.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.2,12.2,,,7.6,19.0,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.2,77.2,,,68.2,84.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.2,82.2,,,72.1,89.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.5,14.5,,,8.4,23.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.5,10.5,,,9.4,11.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.6,39.6,,,34.2,45.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,64.4,64.4,,,56.6,71.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.5,11.5,,,7.5,17.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.6,15.6,,,12.8,18.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.0,82.0,,,74.7,87.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,65.1,65.1,,,57.0,72.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,CRDPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.2,12.2,,,7.8,18.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.1,12.1,,,11.0,13.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,19.7,19.7,,,12.1,30.4,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.1,81.1,,,73.9,86.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.7,35.7,,,30.5,41.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.8,11.8,,,10.8,12.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,21.3,21.3,,,12.6,33.5,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,21.7,21.7,,,13.8,32.5,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.4,40.4,,,35.0,46.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.3,41.3,,,36.1,46.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.9,14.9,,,8.3,25.3,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,CRDPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,CRDPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_2,CRDPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.2,34.2,,,25.8,43.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.0,6.0,,,3.4,10.6,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,CRDPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,67.1,67.1,,,53.9,78.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,23.6,23.6,,,13.0,39.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,CRDPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_2,CRDPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,AGEADJPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,CRDPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.7,12.7,,,8.8,17.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_2,CRDPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,AGEADJPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.5,35.5,,,27.2,44.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,61.1,61.1,,,49.1,71.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,AGEADJPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.5,33.5,,,25.1,43.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,CRDPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.5,9.5,,,8.1,11.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_2,CRDPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,CRDPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,22.4,22.4,,,13.0,35.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,CRDPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,67.5,67.5,,,54.4,78.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,CRDPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,CRDPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,CRDPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,61.5,61.5,,,49.1,72.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,CRDPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.4,27.4,,,20.5,35.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,CRDPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,AGEADJPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.6,9.6,,,8.2,11.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,CRDPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_2,CRDPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,AGEADJPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,CRDPREV,RACE,OTH,,,,
